<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="52" height="12" font="1">Apr 15, 2011</text>
<text top="341" left="94" width="428" height="12" font="1">Rabbit antisera against TR4 was generated by fusing cDNA fragments representing the amino-terminal </text>
<text top="353" left="94" width="448" height="12" font="1">region of mouse TR4 (Ala43–Tyr116) into the pET-42a plasmid (Novagen), and then expressed as GST-fusion </text>
<text top="365" left="94" width="444" height="12" font="1">proteins in Escherichia coli BL21-CodonPlus (DE3)-RIL (Stratagene). The fusion protein was affinity-purified  </text>
<text top="377" left="94" width="445" height="12" font="1">with glutathione Sepharose 4B (Amersham) and then used as antigen for the preparation of rabbit antisera.</text>
<text top="485" left="150" width="28" height="12" font="1">Mouse</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="81" height="12" font="1">pfarnham@usc.edu</text>
<text top="134" left="83" width="66" height="12" font="1">Peggy Farnham</text>
<text top="215" left="121" width="36" height="12" font="1">Anti-TR4</text>
<text top="215" left="339" width="137" height="12" font="1">TR4:  official gene name is NR2C2</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="475" height="12" font="1">Doug Engel. Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="60" height="12" font="1">not applicable</text>
<text top="300" left="215" width="49" height="12" font="1">Doug Engel</text>
<text top="521" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="626" left="103" width="267" height="12" font="2">Antibody production: Tanabe et al. EMBO J 2007, 26: 2295-2306. </text>
<text top="638" left="103" width="218" height="12" font="2">ChIP-seq: O’Geen et al. BMC Genomics. 11:689, 2010 </text>
<text top="413" left="94" width="422" height="12" font="1">TR4 (NR2C2) is a member of the nuclear hormone receptor family. It has an N-terminal transactivation </text>
<text top="425" left="94" width="445" height="12" font="1">domain, a central DNA-binding domain with 2 zinc fingers, and a ligand-binding domain at the C terminus. </text>
<text top="437" left="94" width="441" height="12" font="1">The activated receptor/ligand complex is translocated to the nucleus where it binds to hormone response </text>
<text top="449" left="94" width="106" height="12" font="1">elements of target genes.</text>
<text top="599" left="238" width="60" height="12" font="1">not applicable</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="152" left="125" width="192" height="12" font="1">Western blot shows one band of the right size.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="135" left="130" width="406" height="12" font="1">ChIP validation of TR4 and ELK4 binding sites using qPCR and HeLa cells. Relative enrichment was </text>
<text top="147" left="130" width="394" height="12" font="1">calculated over input DNA and plotted on the y axis. Each data point represents the average of </text>
<text top="159" left="130" width="404" height="12" font="1">triplicate ChIP experiments. Rabbit IgG was used as a non-specific control ChIP. Promoter regions </text>
<text top="171" left="130" width="415" height="12" font="1">tested for ChIP enrichment are shown on the x axis. The C-FOS promoter region is used as a positive </text>
<text top="183" left="130" width="416" height="12" font="1">control for ELK4 binding, CDH1 and CDH10 promoter regions were used as negative control regions </text>
<text top="195" left="130" width="423" height="12" font="1">for both, TR4 and ELK4 binding.  12/12 TR4 binding sites identified by ChIPseq confirmed by ChIP-PCR.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
